Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy

Zhongmin Li, Yilun Liu, Xuedong Fang, Zhenbo Shu Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, People’s Republic of ChinaCorrespondence: Zhenbo Shu Email shuzb@jlu.edu.cnAbstract: Molecular targeted therapy, a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Z, Liu Y, Fang X, Shu Z
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/f461ce49a63348e4b6eb09e5a3634b6a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f461ce49a63348e4b6eb09e5a3634b6a
record_format dspace
spelling oai:doaj.org-article:f461ce49a63348e4b6eb09e5a3634b6a2021-12-02T14:40:41ZNanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy1178-2013https://doaj.org/article/f461ce49a63348e4b6eb09e5a3634b6a2021-03-01T00:00:00Zhttps://www.dovepress.com/nanomaterials-enhance-the-immunomodulatory-effect-of-molecular-targete-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Zhongmin Li, Yilun Liu, Xuedong Fang, Zhenbo Shu Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, People’s Republic of ChinaCorrespondence: Zhenbo Shu Email shuzb@jlu.edu.cnAbstract: Molecular targeted therapy, a tumor therapy strategy that inhibits specific oncogenic targets, has been shown to modulate the immune response. In addition to directly inhibiting the proliferation and metastasis of tumor cells, molecular targeted drugs can activate the immune system through a variety of mechanisms, including by promoting tumor antigen processing and presentation, increasing intratumoral T cell infiltration, enhancing T cell activation and function, and attenuating the immunosuppressive effect of the tumor microenvironment. However, poor water solubility, insufficient accumulation at the tumor site, and nonspecific targeting of immune cells limit their application. To this end, a variety of nanomaterials have been developed to overcome these obstacles and amplify the immunomodulatory effects of molecular targeted drugs. In this review, we summarize the impact of molecular targeted drugs on the antitumor immune response according to their mechanisms, highlight the advantages of nanomaterials in enhancing the immunomodulatory effect of molecular targeted therapy, and discuss the current challenges and future prospects.Keywords: nanomaterial, molecular targeted therapy, immunomodulation, immunotherapy, cancer therapyLi ZLiu YFang XShu ZDove Medical Pressarticlenanomaterialmolecular targeted therapyimmunomodulationimmunotherapycancer therapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 1631-1661 (2021)
institution DOAJ
collection DOAJ
language EN
topic nanomaterial
molecular targeted therapy
immunomodulation
immunotherapy
cancer therapy
Medicine (General)
R5-920
spellingShingle nanomaterial
molecular targeted therapy
immunomodulation
immunotherapy
cancer therapy
Medicine (General)
R5-920
Li Z
Liu Y
Fang X
Shu Z
Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
description Zhongmin Li, Yilun Liu, Xuedong Fang, Zhenbo Shu Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, 130033, People’s Republic of ChinaCorrespondence: Zhenbo Shu Email shuzb@jlu.edu.cnAbstract: Molecular targeted therapy, a tumor therapy strategy that inhibits specific oncogenic targets, has been shown to modulate the immune response. In addition to directly inhibiting the proliferation and metastasis of tumor cells, molecular targeted drugs can activate the immune system through a variety of mechanisms, including by promoting tumor antigen processing and presentation, increasing intratumoral T cell infiltration, enhancing T cell activation and function, and attenuating the immunosuppressive effect of the tumor microenvironment. However, poor water solubility, insufficient accumulation at the tumor site, and nonspecific targeting of immune cells limit their application. To this end, a variety of nanomaterials have been developed to overcome these obstacles and amplify the immunomodulatory effects of molecular targeted drugs. In this review, we summarize the impact of molecular targeted drugs on the antitumor immune response according to their mechanisms, highlight the advantages of nanomaterials in enhancing the immunomodulatory effect of molecular targeted therapy, and discuss the current challenges and future prospects.Keywords: nanomaterial, molecular targeted therapy, immunomodulation, immunotherapy, cancer therapy
format article
author Li Z
Liu Y
Fang X
Shu Z
author_facet Li Z
Liu Y
Fang X
Shu Z
author_sort Li Z
title Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
title_short Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
title_full Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
title_fullStr Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
title_full_unstemmed Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
title_sort nanomaterials enhance the immunomodulatory effect of molecular targeted therapy
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/f461ce49a63348e4b6eb09e5a3634b6a
work_keys_str_mv AT liz nanomaterialsenhancetheimmunomodulatoryeffectofmoleculartargetedtherapy
AT liuy nanomaterialsenhancetheimmunomodulatoryeffectofmoleculartargetedtherapy
AT fangx nanomaterialsenhancetheimmunomodulatoryeffectofmoleculartargetedtherapy
AT shuz nanomaterialsenhancetheimmunomodulatoryeffectofmoleculartargetedtherapy
_version_ 1718390210341896192